3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Venous Thromboembolism
16
Neoplasms
9
Treatment of Venous Thromboembolism in Cancer Patients
3
Thrombosis
2
Pulmonary Embolism
2
Multiple Myeloma
2
Venous Thrombosis
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Prevention of Venous Thromboembolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Embolism
1
Dyskinesias
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Darbepoetin alfa
3
Tinzaparin
2
Epoetin Alfa
2
Cisplatin
2
sotorasib
1
romiplostim
1
pegfilgrastim
1
continuous erythropoietin receptor activator
1
Tretinoin
1
Rivaroxaban
1
Nadroparin
1
Gemcitabine
1
Fondaparinux
1
Docetaxel
1
Dalteparin
1
Carboplatin
1
2,2'-dithiodiethanesulfonic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Rivaroxaban
×
Classical hematology
×
Clear all
NCT06314763
2024-04-30
ROSIE
Radboud University Medical Center
Phase 4
Completed
21 enrolled